Monitor for any subsequent amendments that increase the stake above 10% or a conversion to Schedule 13D, which would signal a shift from passive to activist intent. The clustering of multiple 13G filers suggests accumulating institutional interest, but no near-term catalyst is evident from this filing alone.
Price Chart
Executive Summary
BML Investment Partners, L.P. disclosed a 6.1% passive stake in Connect Biopharma Holdings Ltd via Schedule 13G, holding 3,864,400 ordinary shares as of September 30, 2026. The filing is a new position for this filer, adding to a series of recent 13G filings by other investors (Ikarian Capital, Wei Zheng, BioFortune Inc.) over the past six months. The passive nature and moderate stake size suggest a routine investment disclosure with limited immediate market impact.
Key Financial Metrics
Key Facts
- BML Investment Partners, L.P. filed a new Schedule 13G disclosing beneficial ownership of 3,864,400 ordinary shares of Connect Biopharma Holdings Ltd.
- The stake represents 6.1% of shares outstanding as of September 30, 2026.
- Braden M Leonard, as managing member of the general partner, reported aggregate beneficial ownership of 4,264,400 shares (6.77%), including 400,000 shares held directly.
- The filing certifies the securities were not acquired with the purpose of changing or influencing control of the issuer.
- This is the fourth distinct 13G filing on Connect Biopharma in the past six months, following filings by Ikarian Capital (August 2026), Wei Zheng (May 2026), and BioFortune Inc. (April 2026).
Financial Impact
No financial figures disclosed beyond the 6.1% stake; no transaction prices or dollar values provided.
Risk Factors
- The passive certification could be converted to an activist 13D if the investor later seeks to influence management, though no such intent is indicated.
- Multiple passive filers may indicate a fragmented shareholder base, potentially complicating any future capital-raising or strategic initiatives.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001373604-26-000057 |
| Document: 0001373604-26-000057-index.html | 0001373604-26-000057 |
| Document: 0001373604-26-000057.txt | 0001373604-26-000057 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | SC 13G | $0.9450 $0.9090 | ▼ −3.81% | ▼ −2.83% | $0.8144 (−13.82%) |
Sep 30, 2026 27d ago | 8-K | $1.10 $0.9450 | ▼ −14.09% | ▼ −16.00% | $0.8144 (−25.96%) |
Sep 30, 2026 27d ago | Press Release | $1.10 $0.9447 | ▼ −14.12% | ▼ −16.03% | $0.8144 (−25.96%) |
Sep 15, 2026 6w ago | 8-K | $1.17 $1.28 | ▲ +9.40% | ▲ +8.58% | $0.8144 (−30.39%) |
May 12, 2026 24w ago | 8-K | $2.68 $2.38 | ▼ −11.19% | ▼ −11.27% | $0.8144 (−69.61%) |
May 12, 2026 24w ago | Press Release | $2.68 $2.38 | ▲ +11.19% | ▲ +11.27% | $0.8144 (+69.61%) |
Apr 23, 2026 26w ago | 8-K | $2.52 $2.53 | ▲ +0.40% | ▼ −1.08% | $0.8144 (−67.68%) |
Mar 31, 2026 29w ago | 8-K | $2.72 $2.78 | ▲ +2.21% | ▼ −1.56% | $0.8144 (−70.06%) |
Mar 30, 2026 30w ago | Press Release | $2.90 $2.82 | ▼ −2.76% | ▼ −7.06% | $0.8144 (−71.92%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers